The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AstraZeneca revenue dips as Covid medicines decline

Thu, 27th Apr 2023 07:52

(Alliance News) - Stocks in London were set to open lower on Thursday, as investors concern continued to mount about the health of the US banking sector after another largely lower finish in New York.

Also likely to hold back early buying on Thursday are two key pieces of economic data from the US due in the London afternoon at 1330 BST: the weekly unemployment claims report and US GDP data.

Markets are expecting annual economic growth to slow to 2.0% in the first quarter of the year from 2.6% a quarter earlier.

"A negative surprise in US GDP could further boost the [US Federal Reserve] doves and pull the rate hike expectations lower," said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.

The Fed will announce its next interest rate decision on Wednesday next week.

In London early Thursday, lender Barclays boasted double-digit returns in the first quarter of 2023. Drug maker AstraZeneca posted only a slight dip in first quarter revenue, despite a decline in Covid-19 medicines.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 18.84 points, or 0.2%, at 7,833.80

----------

Hang Seng: up 0.3% at 19,810.03

Nikkei 225: closed up 0.2% at 28,457.68

S&P/ASX 200: closed down 0.3% at 7,292.70

----------

DJIA: closed down 228.96 points, 0.7%, at 33,301.87

S&P 500: closed down 0.4% at 4,055.99

Nasdaq Composite: closed up 0.5% at 11,854.35

----------

EUR: higher at USD1.1054 (USD1.1046)

GBP: unchanged at USD1.2470 (USD1.2472)

USD: higher at JPY133.77 (JPY133.54)

Gold: higher at USD2,000.68 per ounce (USD1,995.53)

(Brent): lower at USD78.01 a barrel (USD80.29)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

11:00 CEST EU economic sentiment indicator

08:30 EDT US unemployment insurance weekly claims report

08:30 EDT US GDP

10:00 EDT US pending home sales index

16:30 EDT US foreign central bank holdings

16:30 EDT US federal discount window borrowings

----------

The long-awaited gambling White Paper setting out UK government proposals to make regulation of the sector "fit for the digital age" is expected to be published on Thursday. Campaigners are hopeful it will include plans for affordability checks and the introduction of a statutory levy on gambling operators to pay for research, education and treatment of problem gambling. Other measures hoped to feature include a reduction in stakes for online slot games to match those found in land-based gambling and the creation of a gambling ombudsman to deal with customer complaints. However, reports suggest that the majority of measures, including the exact level of stake limits of online slot machines and curbs on digital marketing such as "free" bets or bonuses, will be subject to further consultation, signalling even more delay to long-awaited changes.

----------

Japan's prime minister ordered his government to begin work on increasing the number of women executives in major companies to 30% or more by 2030. Women represented only 11.4% of executives in major listed companies in Japan in 2022, according to a cabinet office survey, although the figure has been rising in recent years. "We seek to have the ratio of women among executives at 30% or more by 2030 in companies that are listed on the Tokyo Stock Exchange's Prime Market," Fumio Kishida told officials at a meeting on gender equality. The Prime Market is the stock exchange's leading sector.

----------

BROKER RATING CHANGES

----------

Berenberg raises Reckitt Benckiser price target to 7,840 (7,575) pence - 'buy'

----------

Barclays raises Smith & Nephew price target to 1,200 (1,100) pence - 'underweight'

----------

HSBC cuts Smith & Nephew to 'hold' - price target 1,350 pence

----------

COMPANIES - FTSE 100

----------

Barclays said all three of its businesses performed well in the first quarter of 2023, with high-quality income growth and double-digit returns. The bank reported pretax profit of GBP2.60 billion, up from GBP2.23 billion a year prior. Total income amounted to GBP7.24 billion, up from GBP6.50 billion. Barclays' return on tangible equity was 15.0%, compared with 11.5% in the same quarter a year prior. Its CET1 ratio was 13.6% at the end of March, down from 13.9% at the end of December. The bank said it remains on track to deliver is 2023 targets, with all its performance metrics in line with or ahead of guidance at the first quarter.

----------

Pharmaceutical firm AstraZeneca said it made a "strong start" to 2023 as it posted only a slight dip in first-quarter revenue, despite a decline in takings from Covid-19 medicines. Revenue in the quarter totalled USD10.88 billion, down 4.5% from USD11.39 billion the previous year. AstraZeneca noted that when excluding the sales of Covid-19 medicines, revenue grew by 15% year-on-year. Pretax profit multiplied to USD2.26 billion from USD553 million. Astra said it expects revenue to increase by a low-to-mid single-digit percentage in 2023 and, when excluding Covid-19 medicines, it is expected to increase by a low double-digit percentage.

----------

Consumer goods firm Unilever noted broad-based growth across all its business groups and geographies in the first quarter of 2023, as it reported turnover totalling EUR14.8 billion, representing a 7.0% increase against the previous year. It noted that underlying sales growth was 10.5% in the quarter. Looking forward, Unilever said it expects to deliver another year of strong underlying growth in 2023, with an improved volume performance compared to 2022. It now expects underlying sales growth for the full-year to be at least at the upper end of its range of 3% to 4%. It maintained its quarterly dividend at EUR0.43.

----------

COMPANIES - FTSE 250

----------

Utility supplier Telecom Plus reported "record" growth in the financial year that ended March 31. It said it exceeded its full-year growth targets, with customer increasing to 886,579 and service numbers increasing to 2.8 million. It noted the growth was achieved organically and against the "ongoing headwind of the market stabilisation charge". Consequently, Telecom Plus expects full-year adjusted pretax profit to be slightly above GBP95 million, in-line with previous guidance. It confirmed its intention to pay a total dividend of 80 pence for the year, up from 57p the year prior. Co-Chief Executives Andrew Lindsay and Stuart Burnett said: "The business has delivered an exceptional performance over the last 12 months, with record results on virtually all metrics."

----------

Inchcape said it made an "excellent start" to 2023, with full-year results expected to be in-line with market consensus, which sees adjusted pretax profit at GBP487 million. The car dealership reported first-quarter revenue of GBP2.7 billion, up 50% against the previous year, benefiting from mergers & acquisitions as well as organic growth across all its regions. Chief Executive Duncan Tait said: "Our first quarter results show a continuation of the trends we experienced at the end of last year, with organic growth underpinned by the improvement in vehicle supply. Growth in the Distribution segment was further accelerated by the significant contribution from new businesses in the Americas - with Derco, Simpson Motors and Ditec all contributing positively."

----------

OTHER COMPANIES

----------

PPHE Hotel said it delivered a performance above pre-pandemic levels in its largest market - the UK and the Netherlands - in the first quarter of 2023. The hotel and resort operator reported revenue of GBP68.8 million, up sharply from GBP32.0 million in the previous year and 10% higher than the GBP62.5 million achieved in the first quarter of 2019. Total room revenue amounted to GBP50.4 million, up from GBP22.5 million in the previous year and 16% higher than GBP43.5 million in the first quarter of 2019. Average room rate increased to GBP143.7 from GBP124.1 year-on-year. Against 2019, average room rate increased 25% from GBP115.5. Chief Executive Boris Ivesha said that the momentum experienced in the first quarter is moving into the second quarter. "This affords us great optimism for the rest of the year, with forward bookings for summer and peak season also very healthy," he said.

----------

The year is off to a stronger start than expected at Deutsche Bank, with first quarter pretax profit growing 12% to EUR1.85 billion. This is the highest quarterly profit result since 2013, the bank said. In releasing its first quarter results, Germany's largest lender announced it wants to drive earnings even higher and so will find way to further cut costs. Deutsche Bank said it plans to enact "workforce reductions in non-client facing staff" and "focused reductions in management layers." It also plans to streamline its construction financing business and further downsize its technology centre in Russia. CEO Christian Sewing said the Frankfurt-based institution is "well on track" to meeting or exceeding its 2025 targets.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.